The triple therapy for chronic obstructive pulmonary disease increases the risk of pneumonias compared to the dual-bronchodilator therapy - Watanabe, Keisuke; Horita, Nobuyuki; Kaneko, Takeshi (Journal of Thoracic Disease; Vol 13, No 10 (October 31, 2021): Journal of Thoracic Disease, 2021)